Literature DB >> 20644037

Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature.

Amélie Osio1, Sylvie Fraitag, Smail Hadj-Rabia, Christine Bodemer, Yves de Prost, Dominique Hamel-Teillac.   

Abstract

BACKGROUND: Tufted angioma (TA) is a rare benign vascular tumor that mostly appears during infancy or early childhood. Histologic tufts of capillaries infiltrating the whole dermis in a "cannonball" distribution pattern associated with dilated lymphatic vessels are characteristic of the disease and confirm the diagnosis. Few case series of TA have been published, and the morphologic structure and evolution of TA seem to vary. OBSERVATIONS: We describe the largest series to date of childhood TA, comprising 13 cases. All children developed lesions within the first year of life; 7 cases were congenital. We found a clear male predominance (9 of 13 children). Presentation was a nascent or florid tumor, usually a dusky red to violaceous plaque, that was indurated, firm, and sometimes associated with hyperhidrosis or hypertrichosis. Locations of the lesions included limbs, abdomen, and genitalia. Five children had spontaneous regression, 5 children had Kasabach-Merritt syndrome, and 1 child had a lesion that stabilized. Two children with painful TA had chronic coagulopathy without thrombocytopenia that was controlled by ticlopidine hydrochloride and aspirin.
CONCLUSIONS: The following 3 clinical patterns could be distinguished: TA without complications, TA complicated by Kasabach-Merritt syndrome, and TA without thrombocytopenia but with chronic coagulopathy. To our knowledge, this study is the first to describe the third pattern. Because of the aggressive nature of Kasabach-Merritt syndrome, it is essential to obtain a complete blood cell count when evaluating a child with TA.

Entities:  

Mesh:

Year:  2010        PMID: 20644037     DOI: 10.1001/archdermatol.2010.135

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  15 in total

1.  Tufted angioma with associated Kasabach-Merritt phenomenon caused by somatic mutation in GNA14.

Authors:  Young H Lim; Carmen Fraile; Richard J Antaya; Keith A Choate
Journal:  Pediatr Dermatol       Date:  2019-08-18       Impact factor: 1.588

2.  [Vascular anomalies. Part I: vascular tumors].

Authors:  S Mylonas; S Brunkwall; J Brunkwall
Journal:  Chirurg       Date:  2018-03       Impact factor: 0.955

Review 3.  Classification of Vascular Anomalies: An Update.

Authors:  Jack E Steiner; Beth A Drolet
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

4.  Tufted Angioma of the Index Finger Middle Phalanx.

Authors:  Brooke K Pfister; Erik C King; Jonathan D Samet; Jessica Gulliver; Sigrid F Wolf
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-07-14

Review 5.  Acquired tufted angioma of upper lip: case report and review of the literature.

Authors:  Amarpreet Sabharwal; Alfredo Aguirre; Talal M Zahid; Germain Jean-Charles; Michael N Hatton
Journal:  Head Neck Pathol       Date:  2013-03-23

6.  Tufted angioma successfully treated with topical timolol gel-forming solution.

Authors:  Biswanath Behera; Raj Remya; Laxmisha Chandrashekar; Devinder Mohan Thappa; Debasis Gochhait
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

Review 7.  Vascular Anomalies of the Head and Neck: A Pediatric Overview.

Authors:  Juan Putra; Alyaa Al-Ibraheemi
Journal:  Head Neck Pathol       Date:  2021-03-15

8.  Multifocal Annular Tufted Angioma: An Uncommon Clinical Entity.

Authors:  Debabrata Bandyopadhyay; Abanti Saha
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

9.  A tufted angioma.

Authors:  Aeerabolli Prasuna; Potharaju Narasimha Rao
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

10.  Tufted angioma (Angioblastoma) of eyelid in adults-report of two cases.

Authors:  Ruchi Mittal; Devjyoti Tripathy
Journal:  Diagn Pathol       Date:  2013-09-17       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.